• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Glenmark gets US FDA nod for hypertension drug

      Posted AtBusiness-Standard.com

      Drug maker Glenmark Generics, a group firm of Glenmark Pharmaceuticals, has received approval from the US drug regulator for its anti-hypertension tablets.

      "Glenmark Generics Ltd has received ANDA approval from the United States Food and Drug Administration for Verapamil 240mg tablets," Glenmark Pharmaceuticals said in a statement today.

      Verapamil is a generic version drug which is used for the management of essential hypertension.

      The total sales of Verapamil for the 12-month ended June 2009 was $65 million, according to an industry estimate.

      The company will soon commence marketing and distribution in the US market, Glenmark Generics said.

      "This approval and launch holds significance for Glenmark Generics as it marks our entry into the extended release segment which is a differentiated and niche segment," Glenmark Generics CEO Terrance Coughlin said.

      September 23, 2009


      Share this Article!

    Back to top^